Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiovascular Systems Inc (NASDAQ:CSII)

During the Trading Day
28.96 -0.88 / -2.95%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
28.83 -0.1314 / -0.45%
 
Volume: 11.8K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$946.2M

Company Description

Cardiovascular Systems, Inc. is a medial device company that develops and sells devices for treating cardiovascular diseases. It focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. The company's products such as diamondback 360° PAD system and the stealth 360° PAD system are catheter based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee. It was formerly known as Replidyne, Inc. Cardiovascular Systems was founded in 2000 and is headquartered in St. Paul, MN.

Contact Information

Cardiovascular Systems, Inc.
651 Campus Drive
St. Paul Minnesota 55112-3495
P:(651) 259-1600
Investor Relations:

Employees

Shareholders

Mutual fund holders39.52%
Other institutional37.02%
Individual stakeholders20.86%

Top Executives

David L. MartinPresident, Chief Executive Officer & Director
Kevin J. KennyChief Operating Officer
Laurence L. BetterleyChief Financial Officer
Michael X. YangVice President-Science & Research
James E. FlahertySecretary & Chief Administrative Officer